About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
Gastrointestinal Cancers
Genitourinary Cancers
Hematologic Malignancies
Lung Cancers
Breast Cancers
General Oncology
Palliative Care
Business & Clinical Practice
Event
Hematologic Malignancies
06:39
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
Frontline Therapy in CLL: Obinutuzumab + Ibrutinib, Ibrutinib vs. Chemoimmunotherapy
FEATURING
Ian W. Flinn
111 views
March 16, 2021
1
07:09
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
ELEVATE TN Data on Acalabrutinib - Practice Changing Trial in CLL
FEATURING
Ian W. Flinn
217 views
March 16, 2021
11:47
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
Treatment Options for Newly Diagnosed Myeloma: Time to Incorporate CD38 Antibodies?
FEATURING
Jesus Berdeja
185 views
March 13, 2020
1
09:00
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
Treatment Options in R/R Multiple Myeloma: Tips for Selecting Among the Myriad of Choices
FEATURING
Jesus Berdeja
630 views
March 13, 2020
3
12:36
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
Future Directions in Multiple Myeloma: Selinexor Approval, Venetoclax, Belantamab Mafodotin, BCMA:CD3 Bispecifics & CAR T
FEATURING
Jesus Berdeja
52 views
March 13, 2020
18:23
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
Time Limited Therapy in CLL, Ibrutinib vs Zanubrutinib in WM & LOXO-305 in B-cell Malignancies
FEATURING
Ian W. Flinn
71 views
March 13, 2020